Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications
Jie Fang, Chen-Huan Yu, Xuejian Li, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Raquel Benedé‐Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 47
Metabolic dysfunction-associated steatotic liver disease and its link to cancer
Markos Kalligeros, Linda Henry, Zobair M. Younossi
Metabolism (2024) Vol. 160, pp. 156004-156004
Closed Access | Times Cited: 16
Interactions of non-starch polysaccharides with the gut microbiota and the effect of non-starch polysaccharides with different structures on the metabolism of the gut microbiota: A review
Yujiao Sun, Jun Yao, Rui Gao, et al.
International Journal of Biological Macromolecules (2025) Vol. 296, pp. 139664-139664
Closed Access | Times Cited: 1
The Role of Gut Dysbiosis in the Loss of Intestinal Immune Cell Functions and Viral Pathogenesis
Farzaneh Fakharian, Siva Thirugnanam, David A. Welsh, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1849-1849
Open Access | Times Cited: 39
Journey of the Probiotic Bacteria: Survival of the Fittest
Allyson Andrade Mendonça, Walter de Paula Pinto-Neto, Giselle Alves da Paixão, et al.
Microorganisms (2022) Vol. 11, Iss. 1, pp. 95-95
Open Access | Times Cited: 37
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
Gao-Xin Xu, Wei Song, Chao Yu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 27
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1189-1204
Closed Access | Times Cited: 27
Polysaccharide from Panax japonicus C.A. Mey prevents non-alcoholic fatty liver disease development based on regulating liver metabolism and gut microbiota in mice
Yi Wu, Wen Yin, Ping Hao, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129430-129430
Closed Access | Times Cited: 8
Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
Yuezhi Zhu, Jen Kit Tan, Jia Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 329-329
Open Access | Times Cited: 8
The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis
Ehsan Amini‐Salehi, Soheil Hassanipour, Mohammad‐Hossein Keivanlou, et al.
Nutrition Reviews (2023) Vol. 82, Iss. 6, pp. 815-830
Closed Access | Times Cited: 17
Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
Qin Guo, Yun Li, Xin Dai, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3722-3722
Open Access | Times Cited: 17
Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
Alejandra Mijangos-Trejo, Natalia Nuño‐Lámbarri, Varenka J. Barbero-Becerra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14918-14918
Open Access | Times Cited: 17
Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database
Mary Nemer, Fauzia Osman, Adnan Said
Annals of Hepatology (2024) Vol. 29, Iss. 3, pp. 101491-101491
Open Access | Times Cited: 7
Sodium butyrate alleviates free fatty acid-induced steatosis in primary chicken hepatocytes via the AMPK/PPARα pathway
Jiayi Ding, Jiuyue Liu, Jinyan Chen, et al.
Poultry Science (2024) Vol. 103, Iss. 4, pp. 103482-103482
Open Access | Times Cited: 6
A review of MASLD-related hepatocellular carcinoma: progress in pathogenesis, early detection, and therapeutic interventions
Ma Yang, Jinguo Wang, Wenping Xiao, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 6
Protective effects of Abrus cantoniensis Hance against liver injury through modulation of intestinal microbiota and liver metabolites
Chang Xu, Munwar Ali, Jingyi Sun, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 279, pp. 116495-116495
Open Access | Times Cited: 5
BefA protein alleviates progression of non-alcoholic fatty liver disease by modulating the AMPK signaling pathway through the gut-liver axis
Jie Luo, Yujie Cai, Chao Jia, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139446-139446
Closed Access
The association between the dietary index for gut microbiota and non-alcoholic fatty liver disease and liver fibrosis: evidence from NHANES 2017–2020
Ce Zheng, Zeming Qi, Rui Chen, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Gut microbiota and eye diseases: a bibliometric study and visualization analysis
Xiangyu Fu, Haishan Tan, Ling Huang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 15
Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance
Kyoung Jin Choi, Mi Young Yoon, Ji‐Eun Kim, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease—Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Florentina Ioniţă‐Radu, Cristina Patoni, Andreea Simona Nancoff, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4201-4201
Open Access | Times Cited: 4
Role of Probiotics in Gut Microbiome and Metabolome in Non-Alcoholic Fatty Liver Disease Mouse Model: A Comparative Study
Tian Wu, Zheng Zeng, Yanyan Yu
Microorganisms (2024) Vol. 12, Iss. 5, pp. 1020-1020
Open Access | Times Cited: 4
Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
Jelena Popov, Tijana Despot, David Avelar Rodríguez, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1668-1668
Open Access | Times Cited: 4
Berberine alleviates high-energy and low-protein diet-induced fatty liver hemorrhagic syndrome in laying hens: Insights from microbiome and metabolomics
Xinyi Cheng, Yang Hu, Jun Kuang, et al.
Poultry Science (2024) Vol. 103, Iss. 8, pp. 103968-103968
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top